PyroDex is a Baltimore-based company specializing in pyrogen testing systems, offering prompt and reliable findings through their Monocyte Activation Test (MAT) technology. Their comprehensive approach detects various types of contaminants, including endotoxins, molds, yeasts, viruses, and Gram-positive bacteria, ensuring the safety of medical drugs and devices. With their automated MAT technology, PyroDex provides accurate and quantifiable results within a short turnaround time, enabling clients to bring their products to market faster.
By utilizing human-sourced monocytes, PyroDex's MAT technology mimics the fever response to contaminants in vivo, offering consistent and quantifiable results that provide statistical confidence among product batches. Their unparalleled comprehensive view of a product's safety status allows for the detection of any contaminant that may cause fever, sepsis, multiple organ failure, or death, regardless of its specific molecular structure. With a focus on safer medical drugs and devices, PyroDex aims to improve treatment and save lives.
Generated from the website